News for: 19 february 2021 in category:
Research has shown that fidaxomicin, an antibiotic commonly used to treat intestinal infections, prevents the growth of resistant strains of Mycobacterium tuberculosis (MTb) that cause tuberculosis in the laboratory.
Health
19 February 2021, 20:43 (NeBoley.com.ua)